Mr. Steimle is a partner with significant litigation experience. Since joining the firm in 1999, he has represented clients in California state and federal courts in a variety of complex litigation, including pharmaceutical, toxic tort, commercial, and antitrust lawsuits.

Mr. Steimle currently represents a major pharmaceutical company in the defense of personal injury cases in state and federal courts throughout California which involve claims that plaintiffs sustained degeneration of shoulder joint cartilage (chondrolysis) as a result of the post-operative administration of anesthetic to their shoulder joints.

Mr. Steimle also represents a major pharmaceutical company in the defense of claims that an antipsychotic medication causes weight gain, diabetes, and pancreatitis, which are pending in state and federal courts in San Francisco, Los Angeles, and Sutter County.

Mr. Steimle successfully defended The Dow Chemical Company in numerous product liability actions in San Francisco, Los Angeles, and Orange Counties, in which it was alleged to be the successor to a manufacturer of the Salk polio vaccine. Mr. Steimle prepared and argued successful pleadings challenges that ultimately led to the statewide dismissal of plaintiffs’ claims.

Mr. Steimle also successfully represented SmartHealth Inc. in the defense of the latex glove product liability cases in California.

Mr. Steimle currently represents American Cyanamid Company in a lead paint public nuisance lawsuit prosecuted by several cities and counties in California.

Mr. Steimle successfully represented Union Oil Company of California in defense of multiple personal injury claims involving alleged exposure to methyl tertiary butyl ether (“MTBE”).

Mr. Steimle represents American Cyanamid Company, Chevron U.S.A. Inc., Cytec Engineered Materials Inc., The Dow Chemical Company, Fiberite Inc., Rhodia Inc., Texaco Inc., Unocal Corporation, and in asbestos product liability and premises liability actions throughout California.

Mr. Steimle also has represented chemical manufacturers in product liability claims based upon alleged exposure to benzene.

Mr. Steimle presently represents a network solutions provider in defense of commercial litigation relating to the sales of its products abroad.

Mr. Steimle currently is defending a major specialty chemicals company in commercial litigation pending in federal court in the Central District of California.

Mr. Steimle has successfully represented Rhodia Inc. in commercial litigation involving contracts covering the provision of uniforms for its employees.

Mr. Steimle currently represents a major pharmaceutical company in a California state action by pharmacies alleging a price-fixing conspiracy among manufacturers of brand name drugs in violation of the Cartwright Act and California's Unfair Competition Laws